Belgia - fransk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - baclofène 25 mg - comprimé - 25 mg - baclofène 25 mg - baclofen

USA - engelsk - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen 10 mg - indications and usage baclofen tablets are useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases. baclofen is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson's disease has not been established and, therefore, it is not recommended for these conditions. contraindications baclofen tablets are contraindicated in patients with a hypersensitivity to baclofen.

Israel - engelsk - Ministry of Health

propharm ltd - baclofen - solution for injection - baclofen 10 mg / 5 ml - baclofen - baclofene bioindustria l.i.m. 10mg/5ml is indicated in patients with severe chronic spasticity resulting from trauma, multiple sclerosis or other spinal cord disorders, who are unresponsive to oral baclofen or other orally administered antispastic agents and/or those patients who experience unacceptable side effects at effective oral doses.baclofene bioindustria l.i.m. 10mg/5ml is effective in adult patients with severe chronic spasticity of cerebral origin, resulting e.g. from cerebral palsy, brain trauma or cerebrovascular accident; however, clinical experience is limited.pediatric population:baclofene bioindustria l.i.m. 10mg/5ml is indicated in patients aged 4 to <18 years with severe chronic spasticity of cerebral origin or of spinal origin (associated with injury, multiple sclerosis, or other spinal cord diseases) who are unresponsive to orally administered antispastics (including oral baclofen) and/or who experience unacceptable side effects at effective oral doses.

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pharmaceuticals works polpharma s.a., poľsko - baklofén - 63 - myorelaxantia

Slovakia - slovakisk - ŠÚKL (Štátny ústav pre kontrolu liečiv)

pharmaceuticals works polpharma s.a., poľsko - baklofén - 63 - myorelaxantia

Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

pharmaceutical works polpharma s.a. - Баклофен - 10 mg tablets

Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

pharmaceutical works polpharma s.a. - Баклофен - 25 mg tablets

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

g.e.s. genericos españoles laboratorio, s.a. - baclofeno - excipientes: cloruro de sodio - agentes relajantes musculares de acciÓn central - otros agentes de acción central - baclofeno

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

g.e.s. genericos españoles laboratorio, s.a. - baclofeno - excipientes: cloruro de sodio - agentes relajantes musculares de acciÓn central - otros agentes de acción central - baclofeno

Spania - spansk - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

g.e.s. genericos españoles laboratorio, s.a. - baclofeno - excipientes: cloruro de sodio - agentes relajantes musculares de acciÓn central - otros agentes de acción central - baclofeno